ArticleOncotarget2016

The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer.

Fabien J Cousin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.